Pursuant to Regulation 26(7) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, Sanofi Consumer Healthcare India has informed that recommendations given by the Committee of Independent Directors at its meeting held on 10th April 2025 to the public shareholders on the open offer made by Opal Bidco SAS (‘Acquirer’) together with Clayton, Dubilier & Rice Fund XII, L.P., (a person acting in concert with the Acquirer), has been published today 11th April 2025 in the newspapers: The Financial Express (English) in All editions, Jansatta (Hindi) in All editions, Navshakti (Marathi) in Mumbai editions. A copy of the publication is enclosed and the same is also available on the website of the Company at Newspaper Advertisement.
The above information is a part of company’s filings submitted to BSE.
